After bypass surgery, your original clogged arteries stay in place, and in most cases, the blockages in them get worse over time. The bypass graft reroutes blood around the blockage rather than removing it, so the diseased artery remains part of your circulation. Within one year, about 44% of bypass patients develop at least one new complete blockage in a native coronary artery. But the story is more nuanced than simple worsening: some arteries actually see their blockages shrink, and the type of graft used makes a significant difference in what happens next.
The Bypass Doesn’t Fix the Original Artery
A common misconception is that bypass surgery repairs the blocked vessel. It doesn’t. The surgeon takes a healthy blood vessel from your chest, arm, or leg and attaches it to reroute blood flow around the obstruction. Your original artery, plaque and all, remains exactly where it was. It still carries some blood, still connects to the same network, and still has the same underlying disease that caused the blockage in the first place.
What changes is the flow dynamics. Once a graft provides a new, easier path for blood, the original artery often carries less blood through the narrowed section. This sets off a chain of events that can accelerate the artery’s decline.
Why Bypassed Arteries Often Get Worse
The phenomenon behind this acceleration is called competitive flow. When the graft delivers blood to the same territory as the native artery, the two sources essentially compete. Blood takes the path of least resistance, and if the graft provides a smooth, open channel, less blood pushes through the narrowed original artery. Reduced flow through a vessel encourages the artery walls to narrow further and makes existing plaque more likely to progress.
The numbers are striking. Over five years, disease progression was observed in about 35% of vessels upstream of a bypass graft, and left main artery disease progressed in over 16% of cases. One study found that atherosclerosis progression was more than 10 times more frequent in bypassed arteries with mild disease compared to similar arteries that hadn’t been bypassed. In other words, the very act of grafting a vessel can accelerate the disease in the original artery.
Arteries with the most severe pre-operative narrowing are at highest risk. When the original blockage was already over 90% before surgery, the chance of that artery becoming completely occluded within a year was about 46%, compared to roughly 10% for arteries with less severe narrowing.
The Graft Type Matters
Not all grafts affect the native artery equally. Surgeons use two main types: arterial grafts (typically from the chest wall) and vein grafts (usually taken from the leg). The type of graft has a measurable impact on what happens to the original artery underneath.
Arteries bypassed with vein grafts tend to fare worse. Complete blockages are more common in vessels bypassed with vein grafts compared to those receiving an arterial graft. The left anterior descending artery, which is almost always grafted with the left internal thoracic artery (a chest wall artery), had a new complete blockage rate of only 18% at one year and about 9% over nearly five years. Non-left anterior descending arteries, more often bypassed with vein grafts, had higher occlusion rates of around 14% over the same follow-up period.
This difference likely comes down to the biological compatibility of arterial grafts. Arteries grafted with arterial conduits release substances that help protect the vessel wall, and they match the native artery’s structure more closely than veins do.
Some Blockages Actually Shrink
Here’s the surprising part: not every bypassed artery gets worse. About 45% of bypass patients show regression (meaning reduction) of disease in at least one vessel after surgery. Overall, roughly 20% of all native vessel blockages showed some degree of improvement on follow-up imaging.
Several factors predicted whether a blockage would shrink. Arteries receiving an arterial graft had a higher regression rate (21%) compared to those with vein grafts (16%). Blockages in the left-sided arteries regressed more often than those on the right side (23% versus 14%). And more severe blockages, those at 70% or greater narrowing, were more likely to regress than moderate ones (22% versus 10%). The reasons aren’t fully understood, but changes in blood flow patterns and wall stress after grafting likely play a role.
What Happens If the Original Artery Closes Completely
If the graft is working well, you may feel nothing at all when the native artery finishes closing off. The graft is already delivering blood to that territory, so the heart muscle supplied by that artery continues to receive oxygen. Many complete occlusions of native arteries after bypass are discovered incidentally on imaging done for other reasons.
The real danger is when both the native artery and its graft fail. This occurred in about 8% of patients at one year in one study. When that happens, the heart muscle in that territory loses its blood supply entirely, which can cause chest pain, shortness of breath, fatigue, or in serious cases, a heart attack. Some people with total occlusions experience symptoms that worsen with physical activity, including chest tightness, dizziness, or an irregular heartbeat. Others have no symptoms at all.
Reverse Flow: When Blood Goes Backward
In some cases, the native artery is open enough that blood actually flows backward from the artery into the graft, rather than the other way around. This is called reverse flow, and it occurred in about 5% of patients with chest wall artery grafts in one study. When this happens, the graft isn’t really contributing to heart muscle perfusion, even though it’s technically open. It’s essentially a redundant tube. Over time, grafts experiencing persistent reverse flow may narrow or close because they’re not being used meaningfully.
How Medication Protects Both Arteries and Grafts
Cholesterol-lowering medications, particularly statins, are a cornerstone of post-bypass care, and their effect on both native arteries and grafts is substantial. Intensive lipid-lowering therapy slows plaque progression in bypassed arteries, reduces the risk of major cardiac events, and decreases the chance of needing another procedure.
The mechanism goes beyond simply lowering cholesterol. Statins stabilize existing plaques by thickening the fibrous cap that covers them, making rupture less likely. Patients on established statin therapy had ruptured plaques only 8% of the time, compared to 36% in those not taking statins. The drugs also reduce inflammation in the artery wall, decrease the accumulation of immune cells inside plaques, and limit the enzymes that break down plaque structure. In animal studies, statins increased the structural protein content of plaques while reducing their fatty core, essentially converting dangerous, fragile plaques into more stable ones.
This is why post-bypass patients are placed on aggressive cholesterol management regardless of their pre-surgery cholesterol levels. The goal isn’t just to prevent new blockages but to stabilize the ones that already exist in the native arteries that weren’t removed during surgery.
The Long-Term Picture
Bypass surgery buys time, but it doesn’t cure the underlying disease. Your native arteries will continue to be affected by atherosclerosis, and bypassed vessels are at higher risk of progression than arteries that weren’t grafted. The BARI trial, one of the largest studies comparing bypass outcomes, found that disease progression in native arteries was actually more common than graft failure as a cause of returning symptoms like chest pain.
The practical takeaway is that the original blockages don’t disappear after surgery, and the arteries around them remain active participants in your cardiovascular health. The best outcomes come from treating bypass as one component of a broader strategy that includes lipid control, blood pressure management, and lifestyle changes that slow the progression of the disease your arteries still carry.